Clovis Oncology Buy Hold or Sell Recommendation
| CLVSDelisted Stock | USD 0.09 0.02 24.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Clovis Oncology is 'Not Rated'. Macroaxis provides Clovis Oncology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CLVS positions. The advice algorithm takes into account all of Clovis Oncology's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Clovis Oncology's buy or sell advice are summarized below:
Real Value 0.0884 | Hype Value 0.09 | Market Value 0.093 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Clovis Oncology given historical horizon and risk tolerance towards Clovis Oncology. When Macroaxis issues a 'buy' or 'sell' recommendation for Clovis Oncology, the advice is generated through an automated system that utilizes algorithms and statistical models.
Clovis |
Execute Clovis Oncology Buy or Sell Advice
The Clovis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Clovis Oncology. Macroaxis does not own or have any residual interests in Clovis Oncology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Clovis Oncology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Clovis Oncology Trading Alerts and Improvement Suggestions
| Clovis Oncology is not yet fully synchronised with the market data | |
| Clovis Oncology has some characteristics of a very speculative penny stock | |
| Clovis Oncology has a very high chance of going through financial distress in the upcoming years | |
| Clovis Oncology has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the previous year's revenue of 148.76 M. Net Loss for the year was (264.52 M) with profit before overhead, payroll, taxes, and interest of 115.3 M. | |
| Clovis Oncology currently holds about 94.58 M in cash with (196.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Clovis Oncology Returns Distribution Density
The distribution of Clovis Oncology's historical returns is an attempt to chart the uncertainty of Clovis Oncology's future price movements. The chart of the probability distribution of Clovis Oncology daily returns describes the distribution of returns around its average expected value. We use Clovis Oncology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Clovis Oncology returns is essential to provide solid investment advice for Clovis Oncology.
| Mean Return | -0.93 | Value At Risk | -15.38 | Potential Upside | 20.97 | Standard Deviation | 13.24 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Clovis Oncology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Clovis Oncology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Clovis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Clovis Oncology Buy or Sell Advice
When is the right time to buy or sell Clovis Oncology? Buying financial instruments such as Clovis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Clovis Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Clovis Stock
If you are still planning to invest in Clovis Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clovis Oncology's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |